ACE and metabolic syndrome: The discovery might lead to an ACE gene genotype that might be used as a biomarker for the likelihood of obesity, dyslipidemia, and type 2 diabetes mellitus among hypertensive patients for the early detection and prevention of hypertension-related comorbidities.